AVARIJN2 study
- Conditions
- Aortic valve stenosis
- Registration Number
- NL-OMON21621
- Lead Sponsor
- Erasmus Medical Center, Department of Cardio-thoracic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 59
Inclusion Criteria
Adult patients, mentally competent and 18 years of age or older
-Inclusion in the AVARIJN study
Exclusion Criteria
-Patients who are not able to give informed consent
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective is to determine the quality of life assessed with the SF-36V2¢â questionnaire in asymptomatic patients with severe aortic stenosis, the mortality (all-cause and specific cause) as well as the determination of the aortic valve function by an echocardiogram.
- Secondary Outcome Measures
Name Time Method The secondary objective is to depict the emanated complications occurred during follow-up.